Award
National Cancer Institute 5R01CA204302-10
Characterization of YAP as a rational companion target in lung cancer
Recipient
Not specified
Award Amount
$383,563.00
Ceiling
$383,563.00
Awarded
December 15, 2025
Identifier
5R01CA204302-10
Award for research on YAP signaling in lung cancer drug resistance funded by the National Cancer Institute with an amount of $383,563.
Description
This project focuses on the role of YAP signaling in drug resistance in lung cancer, with potential for clinical translation. The award is funded by the National Cancer Institute, part of NIH, with a total award amount of $383,563 for the fiscal year 2026.